Five patients with pulmonary mucormycosis diagnosed during life are describ
ed. AU had underlying predisposing conditions: either posttransplant or hem
atologic malignancies. In all cases, the diagnosis mas made using fiberopti
c bronchoscopy. In three patients, BAL was diagnostic. In two of these pati
ents, the diagnosis was made by identifying the typical hyphae of mucormyco
sis in the Brit fluid alone. Transbronchial biopsy was diagnostic in three
patients. Treatment was based on IV antifungal chemotherapy together with s
urgical removal of involved lung tissue whenever feasible. The clinical out
come of these patients was dismal and was determined primarily the underlyi
ng condition.